Project FAVA: nonprofit working to drive medical research to treat the painful fibro adipose vascular anomaly, a rare disease connected to the PIK3CA mutation.

Joined July 2019
Fantastic news today for patients with PIK3CA related disorders (PROS)! Alpelisib obtained FDA approval. This is for us a fantastic achievement. We started in 2016, identified alpelisib (BYL719) has a promising compound and developed a mouse model. 1/n fda.gov/drugs/resources-info…
8
37
8
111
What do you know about FAVA? Click to find out what you should know from the real experts: those suffering from it. #RareDisease #RareDiseaseDay @rarediseaseday @rarediseasesint @RareDiseases @GlobalGenes
Sirolimus Leads to Rapid Improvement in Fibroadipose Vascular Anomalies @ISSVA_org #FAVA
5
1
12